Venetoclax 100mg Tablet (Generic Venclexta®) – Ikra 100mg by Zydus

Venetoclax 100mg Tablet is a prescription BCL-2 inhibitor used for the treatment of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and certain patients with Acute Myeloid Leukemia (AML). Ikra 100mg, manufactured by Zydus, is a generic equivalent of Venclexta® (AbbVie). Venetoclax works by selectively inhibiting the BCL-2 protein, helping cancer cells undergo programmed cell death (apoptosis). Buy from a trusted international pharmacy with worldwide delivery.

Product Information

• Generic Name: Venetoclax 100mg
• Generic Brand: Ikra 100mg
• Manufacturer: Zydus
• Drug Class: BCL-2 (B-cell Lymphoma-2) Inhibitor
• Brand Reference: Venclexta® (AbbVie)
• Indication: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Acute Myeloid Leukemia (AML)
• Form: Oral Tablet
• Strength: 100mg
• Packing: Manufacturer Dependent
• Route: Oral
• Prescription: Yes
• Evidence: FDA-approved; EMA-approved; NCCN Guideline-supported

How It Works

Venetoclax selectively blocks the BCL-2 protein, which helps cancer cells survive. By inhibiting BCL-2, Venetoclax restores the natural process of apoptosis, allowing leukemia cells to die while slowing disease progression. It is commonly used in combination with other targeted therapies or chemotherapy according to approved treatment protocols.

Availability & Ordering

Patients and healthcare professionals searching for Venetoclax 100mg Tablet, Buy Venetoclax Online, Generic Venclexta®, Ikra 100mg, Zydus Venetoclax, Venetoclax Price USA UK, CLL Medicine, AML Treatment, and BCL-2 Inhibitor can order from a trusted supplier offering secure ordering, discreet packaging, and worldwide delivery.

Frequently Asked Questions

What is Venetoclax 100mg Tablet used for?

It is prescribed for adults with Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and certain patients with Acute Myeloid Leukemia (AML) as part of approved treatment regimens.

Is Venetoclax the same as Venclexta®?

Yes. Venclexta® is the reference brand marketed by AbbVie. Ikra 100mg by Zydus contains the same active ingredient, Venetoclax.

How does Venetoclax work?

Venetoclax blocks the BCL-2 protein, enabling cancer cells to undergo programmed cell death (apoptosis), helping reduce the number of leukemia cells.

Is Venetoclax chemotherapy?

No. Venetoclax is a targeted oral anticancer therapy classified as a BCL-2 inhibitor, not a traditional chemotherapy drug.

Is Venetoclax available internationally?

Yes. Ikra 100mg (Venetoclax 100mg Tablets) by Zydus is available with worldwide delivery where legally permitted.

Last Updated: August 7, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your oncologist before starting or changing any cancer treatment.